Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
Imtiaz Ahmad, Mohammud Alam, Ryan Saadi, Saborny Mahmud, Emily Saadi
doi: https://doi.org/10.1101/2020.05.18.20066902
Imtiaz Ahmad
1Allergy, Sleep & Lung Care, 21st Century Oncology, Fort Myers, FL
MD, MPH, FCCPMohammud Alam
2Infectious Disease Specialist, Cordial Medical PC, Farmingdale, NY
MDRyan Saadi
3Center for Market Access and Medical Innovation, Warren, NJ
6Quantaira Health, New York, NY
MD, MPHSaborny Mahmud
4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Emily Saadi
5Yale University, School of Public Health, New Haven, CT
BS
Article usage
Posted May 22, 2020.
Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
Imtiaz Ahmad, Mohammud Alam, Ryan Saadi, Saborny Mahmud, Emily Saadi
medRxiv 2020.05.18.20066902; doi: https://doi.org/10.1101/2020.05.18.20066902
Subject Area
Subject Areas
- Addiction Medicine (415)
- Allergy and Immunology (736)
- Anesthesia (216)
- Cardiovascular Medicine (3154)
- Dermatology (268)
- Emergency Medicine (468)
- Epidemiology (13120)
- Forensic Medicine (15)
- Gastroenterology (876)
- Genetic and Genomic Medicine (4945)
- Geriatric Medicine (456)
- Health Economics (758)
- Health Informatics (3110)
- Health Policy (1110)
- Hematology (415)
- HIV/AIDS (983)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4698)
- Nursing (249)
- Nutrition (695)
- Oncology (2422)
- Ophthalmology (689)
- Orthopedics (271)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7263)
- Radiology and Imaging (1624)
- Respiratory Medicine (950)
- Rheumatology (464)
- Sports Medicine (408)
- Surgery (525)
- Toxicology (66)
- Transplantation (223)
- Urology (193)